Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Integration of the reverse-transcribed HIV cDNA into the host DNA is a required step in viral replication. The virus-encoded integrase protein catalyzes the initial DNA breaking and joining reactions that mediate cDNA integration. Here, the identification by X-ray crystallography of a small-molecule binding site on the integrase catalytic domain is reported. The small-molecule family studied consists of a core of arsenic or phosphorus surrounded by four aromatic groups. Two arsenic derivatives were visualized bound to integrase. In each case, two molecules bound at symmetry-related sites on the catalytic domain dimer interface. The first compound studied, tetraphenyl arsonium, did not inhibit integrase. However, a synthetic compound substituting a catechol for one of the phenyl rings, dihydroxyphenyltriphenylarsonium, bound to the same site and did inhibit the enzyme. Changes in the vicinity of the catalytic site were seen with the inhibitory compound only, potentially explaining its mechanism of action. Further substituting phosphonium for arsonium yielded a compound with an IC(50) in the low micromolar range. These findings may be useful in designing new inhibitors of integrase, which is at present the only one of the three HIV enzymes for which clinically useful inhibitors are not available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells
Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000) · Science · doi:10.1126/science.287.5453.646 · Cited by 1,131 · cited 1×
“From such screens several IN inhibitors have now been identi®ed, but to date no clinically useful inhibitors have been developed and only a handful display antiviral activity (Hansen et al., 1998; Pommier et al., 1997; Hazuda et al., 2000; King & Robinson, 1998; Reddy et al., 1999).”
BackgroundDyda, F., Hickman, A. B., Jenkins, T. M., Engelman, A., Craigie, R., & Davies, D. R. (1994) · Science · doi:10.1126/science.7801124 · Cited by 810 · cited 3×
“Crystals of 50±212 were obtained by vapor diffusion (1:1 mixture with the protein at 10 mg mlÿ1) at 277 K using 15% PEG 8000, 100 mM cacodylic acid pH 6.5, 200 mM (NH4)2SO4, 5 mM DTT, 5 mM MnCl2 and 5 mM MgCl2 as a precipitant (Greenwald et al., 1999), essentially as reported by Dyda et al. (1994).”
BackgroundMethodInfluentialCraigie, R., Fujiwara, T., & Bushman, F. (1990) · Cell · doi:10.1016/0092-8674(90)90126-y · Cited by 409 · cited 2×
“Prior to integration, two nucleotides are removed from each 30-end in the linear cDNA precursor (terminal cleavage) (Roth et al., 1989; Katzman et al., 1989; Sherman & Fyfe, 1990; Craigie et al., 1990).”
BackgroundSelf-citationKatz, R. A., Merkel, G., Kulkosky, J., Leis, J., & Skalka, A. M. (1990) · Cell · doi:10.1016/0092-8674(90)90290-u · Cited by 346 · cited 1×
“The recessed 30-ends are then joined to protruding 50- ends of breaks made in the target DNA (strand transfer) (Craigie et al., 1990; Bushman et al., 1990; Katz et al., 1990).”
BackgroundRetroviral DNA integration directed by HIV integration protein in vitro
Bushman, F. D., Fujiwara, T., & Craigie, R. (1990) · Science · doi:10.1126/science.2171144 · Cited by 338 · cited 1×
“The recessed 30-ends are then joined to protruding 50- ends of breaks made in the target DNA (strand transfer) (Craigie et al., 1990; Bushman et al., 1990; Katz et al., 1990).”
BackgroundSelf-citationKatzman, M., Katz, R. A., Skalka, A. M., & Leis, J. (1989) · Journal of Virology · doi:10.1128/jvi.63.12.5319-5327.1989 · Cited by 311 · cited 1×
“Prior to integration, two nucleotides are removed from each 30-end in the linear cDNA precursor (terminal cleavage) (Roth et al., 1989; Katzman et al., 1989; Sherman & Fyfe, 1990; Craigie et al., 1990).”
BackgroundRoth, M. J., Schwartzberg, P. L., & Goff, S. P. (1989) · Cell · doi:10.1016/0092-8674(89)90401-7 · Cited by 263 · cited 1×
“Prior to integration, two nucleotides are removed from each 30-end in the linear cDNA precursor (terminal cleavage) (Roth et al., 1989; Katzman et al., 1989; Sherman & Fyfe, 1990; Craigie et al., 1990).”
Background
Cited by
Christ, F., Voet, A., Marchand, A., Nicolet, S., Desimmie, B. A., Marchand, D., Bardiot, D., Van der Veken, N. J., Van Remoortel, B., Strelkov, S. V., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.370 · Cited by 479
Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75
Cherepanov, P., Ambrosio, A. L. B., Rahman, S., Ellenberger, T., & Engelman, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506924102 · Cited by 408
Craigie, R., & Bushman, F. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006890 · Cited by 327
Self-citationRole of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting
Marshall, H. M., Ronen, K., Berry, C., Llano, M., Sutherland, H., Saenz, D., Bickmore, W., Poeschla, E., & Bushman, F. D. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001340 · Cited by 241
“The structure of a complex of the LEDGF/p75 IBD and the IN catalytic domain have been solved by X-ray crystallography[33], and the interaction surface was found to overlap with the binding site seen previously for the integrase inhibitor tetraphenylarsonium [59].”
Self-citationThe lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication
Engelman, A., & Cherepanov, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000046 · Cited by 231
“A compound that ablated HIV-1 IN 39 processing and DNA strand transfer activities in vitro at the relatively modest median inhibition concentration (IC50) of 150 mM bound the CCD at the IBD interaction site [60,89].”
BackgroundMultimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors
Kessl, J. J., Jena, N., Koh, Y., Taskent-Sezgin, H., Slaughter, A., Feng, L., de Silva, S., Wu, L., Le Grice, S. F. J., Engelman, A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.354373 · Cited by 182
Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1
Fader, L. D., Malenfant, E., Parisien, M., Carson, R., Bilodeau, F., Landry, S., Pesant, M., Brochu, C., Morin, S., Chabot, C., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500002n · Cited by 178
New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action
Tsiang, M., Jones, G. S., Niedziela-Majka, A., Kan, E., Lansdon, E. B., Huang, W., Hung, M., Samuel, D., Novikov, N., Xu, Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347534 · Cited by 167
EmrE, a model for studying evolution and mechanism of ion-coupled transporters
Schuldiner, S. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.12.018 · Cited by 164
Balakrishnan, M., Yant, S. R., Tsai, L., O’Sullivan, C., Bam, R. A., Tsai, A., Niedziela-Majka, A., Stray, K. M., Sakowicz, R., & Cihlar, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074163 · Cited by 126
“short peptides that bind the IN dimer interface [26–29] and ii) disrupting IN interaction with LEDGF/p75 [21,27,30].”
A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase
Sharma, A., Slaughter, A., Jena, N., Feng, L., Kessl, J. J., Fadel, H. J., Malani, N., Male, F., Wu, L., Poeschla, E., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004171 · Cited by 124
Self-citationAllosteric Inhibition of Human Immunodeficiency Virus Integrase
Gupta, K., Brady, T., Dyer, B. M., Malani, N., Hwang, Y., Male, F., Nolte, R. T., Wang, L., Velthuisen, E., Jeffrey, J., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.551119 · Cited by 81
“Earlier work has demonstrated that this site can be bound by small molecules (19), and subsequent screening efforts have yielded several small molecule classes that interfere with binding of the LEDGF/p75 IBD and display antiviral activity (reviewed in Refs.”
BackgroundSelf-citationStructural Basis for Inhibitor-Induced Aggregation of HIV Integrase
Gupta, K., Turkki, V., Sherrill-Mix, S., Hwang, Y., Eilers, G., Taylor, L., McDanal, C., Wang, P., Temelkoff, D., Nolte, R. T., et al. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002584 · Cited by 68
Self-citationAn Allosteric Mechanism for Inhibiting HIV-1 Integrase with a Small Molecule
Kessl, J. J., Eidahl, J. O., Shkriabai, N., Zhao, Z., McKee, C. J., Hess, S., Burke, T. R., & Kvaratskhelia, M. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058883 · Cited by 50
Gupta, K., Allen, A., Giraldo, C., Eilers, G., Sharp, R., Hwang, Y., Murali, H., Cruz, K., Janmey, P., Bushman, F., et al. (2021) · Structure · doi:10.1016/j.str.2020.12.001 · Cited by 19
“A second novel class of IN inhibitors have been identified that targets a distal allosteric site on the protein and acts late in viral replication (Christ et al., 2012; Christ et al., 2010; Engelman et al., 2013; Feng et al., 2013; Fontana et al., 2015; Gupta et al., 2014; Jurado et al., 2013; Le Rouzic et al., 2013;…”
BackgroundSelf-citation
Metadata
- Authors
- Molteni, V., Greenwald, J., Rhodes, D., Hwang, Y., Kwiatkowski, W., Bushman, F. D., Siegel, J. S., & Choe, S.
- Venue
- Acta Crystallographica Section D Biological Crystallography
- Published
- 2001-04-01
- Volume
- 57
- Issue
- 4
- Pages
- 536-544
- ISSN
- 0907-4449 (ISSN-L)
- OpenAlex
- W1980725180
- Cited by
- 89
- References
- 7
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.